Literature DB >> 16353164

The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?

Lon S Schneider.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16353164     DOI: 10.1002/gps.1492

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


× No keyword cloud information.
  2 in total

1.  The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer's disease.

Authors:  Steve Iliffe
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Rivastigmine in Alzheimer's disease: Cognitive function and quality of life.

Authors:  Roberta Annicchiarico; Alessia Federici; Carla Pettenati; Carlo Caltagirone
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.